SONIC
Infliximab, azathioprine or combo in CD
CHOICE
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy
ASCEND I
Mesalazine high/low dose in UC
METRO+/- AZA postop
Metronidazol +/- AZA in postop recurrence in CD
PRECiSE 4
Reinduction with certolizumab in CD
Antibiotic combo in CD
Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease
AZA/5ASA postop
AZA/5ASA in postop recurrence in CD
IgG Food antigen CD
Diet intervention study in CD:IgG antibodies against food antigens
Fibrin glue perianal CD
Fibrin glue in perianal CD
SUTD
Step-up vs top-down management in CD